Clinical trials

  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Severe primary dysmenorrhea
  • HYDROCORTISONE for Severe acute infection
  • BJT-778 for Chronic Hepatitis D Infection|Hepatitis D
  • FLUOROESTRADIOL F-18 for Endometriosis
  • ACETYLCYSTEINE for Alcoholic hepatitis
  • AMIVANTAMAB for Recurrent/metastatic head and neck squamous cell carcinoma
  • BIMEKIZUMAB for Axial spondyloarthritis | Psoriasis
  • Testosterone decanoate; Testosterone isocaproate; Testosterone phenylpropionate; Testosterone propionate for Androgen deficiency | Palliative care
  • GLUCAGON for Heart failure with preserved ejection fraction (HFpEF)|Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • AUTOLOGOUS REGULATORY T-CELLS WITH AN IMMUNOPHENOTYPE OF CD4+CD25HI/+FOXP3+ for Ulcerative colitis
  • Nivolumab for Malignant melanoma (resected stage IIB–III)
  • ADX-038 for Complement-mediated kidney disease|IgA nephropathy|C3 glomerulopathy (C3G)|Immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN)